Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2014-03-21 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13006), Bouches-du-Rhone
PHARMACIE DU PALAIS : revenue, balance sheet and financial ratios
PHARMACIE DU PALAIS is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13006),
this company of category PME
shows in 2022 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU PALAIS (SIREN 801231614)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
1 277 545 €
1 097 630 €
1 118 060 €
1 025 064 €
933 967 €
922 003 €
Net income
7 148 €
8 707 €
122 300 €
38 522 €
15 736 €
43 161 €
16 991 €
36 708 €
EBITDA
N/C
N/C
160 809 €
52 184 €
27 104 €
61 608 €
23 010 €
30 094 €
Net margin
N/C
N/C
9.6%
3.5%
1.4%
4.2%
1.8%
4.0%
Revenue and income statement
In 2024, PHARMACIE DU PALAIS generates positive net income of 7 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 37 k€ -> 7 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
7 148 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 100%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
100.364%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.6%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
591.777
496.261
354.536
308.025
248.455
149.348
118.293
100.364
Financial autonomy
12.604
14.628
19.15
20.613
24.222
33.632
38.015
40.6
Repayment capacity
44.329
65.344
15.479
48.228
13.757
4.254
None
None
Cash flow / Revenue
1.746%
1.119%
4.039%
1.122%
3.867%
9.818%
None%
None%
Sector positioning
Debt ratio
100.362024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-6 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU PALAIS (100.36) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.6%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+7 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU PALAIS (40.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.25 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DU PALAIS (4.25) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 95.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
95.06
Liquidity indicators evolution PHARMACIE DU PALAIS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
165.98
139.401
141.256
122.353
134.713
172.941
123.001
95.06
Interest coverage
42.616
50.621
19.689
44.171
18.676
5.1
None
None
Sector positioning
Liquidity ratio
95.062024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch-18 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU PALAIS (95.06) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
5.1x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Good
In 2022, the interest coverage of PHARMACIE DU PALAIS (5.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU PALAIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
139 010 €
146 381 €
149 331 €
135 296 €
109 807 €
76 474 €
0 €
0 €
Inventory turnover (days)
57
50
51
45
39
34
0
0
Customer payment term (days)
5
8
6
3
8
4
0
0
Supplier payment term (days)
45
47
41
49
44
41
0
0
Positioning of PHARMACIE DU PALAIS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU PALAIS is estimated at
99 791 €
(range 69 493€ - 149 293€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
69k€99k€149k€
99 791 €Range: 69 493€ - 149 293€
NAF 5 année 2024
Valuation method used
Net Income Multiple
7 148 €
×
14.0x
=99 791 €
Range: 69 493€ - 149 294€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU PALAIS with other companies in the same sector:
Frequently asked questions about PHARMACIE DU PALAIS
What is the revenue of PHARMACIE DU PALAIS ?
The revenue of PHARMACIE DU PALAIS in 2022 is 1.3 M€.
Is PHARMACIE DU PALAIS profitable?
Yes, PHARMACIE DU PALAIS generated a net profit of 7 k€ in 2024.
Where is the headquarters of PHARMACIE DU PALAIS ?
The headquarters of PHARMACIE DU PALAIS is located in MARSEILLE (13006), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DU PALAIS ?
The tax return of PHARMACIE DU PALAIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU PALAIS operate?
PHARMACIE DU PALAIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart